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While calcium oxalate monohydrate (whewellite: CaC2O4$H2O) kidney stones are related
to hyperoxaluria, calcium oxalate dihydrate (weddellite: CaC2O4$(2 þ x)H2O) ones are
mainly associated with hypercalciuria. Crystalline conversion from weddellite to whe-
wellite introduces a contradiction between Fourier transform infrared (FTIR) spectra which
indicate the presence of whewellite and the fact that bipyramid crystallites, a morphology
speciﬁc of weddellite, can be observed. It constitutes thus a major problem for clinicians as
hyperoxaluria and hypercalciuria are associated with very different aetiologies and
treatments. In this contribution, the complete set of data including neutron diffraction
experiments, observations through a last generation ﬁeld emission scanning electron
microscope as well as 3D and 2D cross-section visualisations derived from the mComputed
Tomography measurements seems to explain some particular features observed on FTIR
spectra related to the crystalline conversion from weddellite to whewellite. The structural
hypothesis which is proposed is related to the formation of amorphous whewellite, a new
polymorph recently synthesised. Thus, in such cases, special attention should be paid to
the stone morphology (and not FTIR spectrum), which is a major element for clinical
diagnosis as already underlined for other types of urinary calculi.
© 2016 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Bazin).
ed by Elsevier Masson SAS.1. Introduction
Analysis of the prevalence of urolithiasis in the last de-
cades reveals an increase of calcium oxalate stones
worldwide [1e6]. Depending on the number of waterThis is an open access article under the CC BY-NC-ND license (http://
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oxalate stones are related to hyperoxaluria or hyper-
calciuria [7e9]. More precisely, kidney stones made of
whewellite (calcium oxalate monohydrate or COM,
CaC2O4$H2O) are induced by hyperoxaluria which can be
intermittent and moderate (Ia), due to low urine output
and stasis (Ib, and Id) or heavy hyperoxaluria as a result of
gut absorption (Ie) or of genetic origin in primary hyper-
oxalurias (Ic) [10e17]. In a previous investigation [18,19],
we provide evidence that each whewellite subtype namely
Ia, Ib, Ic, Id and Ie is associated with a peculiar crystallite
morphology. The other crystalline form, i.e. weddellite
(calcium oxalate dihydrate or COD, CaC2O4$(2 þ x)H2O), is
induced by hypercalciuria. For such kidney stones, sub-
types, IIa, IIb and IIc, also exist.
Crystalline conversion from weddellite to whewellite
introduces a contradiction between Fourier transform
infrared (FTIR) spectra which indicate the presence of
whewellite and the fact that bipyramid crystallites, a
morphology speciﬁc of weddellite, can be observed. It
constitutes thus a major problem for the clinicians as
hyperoxaluria and hypercalciuria are associated with very
different aetiologies and treatments. In the present
contribution, wewould like to understandmore deeply this
crystalline conversion, its relationship with the IR absorp-
tion spectrum. To do that, a set of kidney stones including
ones which display unconventional IR absorption spectra
have been selected. On these pathological concretions
[20e29], FTIR measurements [30,31] have been completed
by observations using a last generation scanning electron
microscope [32], measurements on a neutron diffractom-
eter [18,33e35] as well as 3D and 2D cross-sectionTable 1
Morphology and chemical composition as given by FTIR spectrosc
Sample Morphology FTIR
N68096 Ia 100%
N68214 Ia 100%
N55348 Ia 100%
N52350 Ia 100%
N68102 Ia 96%C
N68074 Ia þ IIb 65%C
N68140 Ia þ IIb 64%C
N68258 Ia þ IIb 80%C
N57404 Ia þ IVa þ IIb 49%C
N52299 Id 100%
N69923 Ie 87%C
N68076 IIb 52%C
N68097 IIb 80%C
N68285 IIb 56%C
N68114 IIb þ Ia 50%C
N68231 IIb þ IVb 36%C
N68316 IIb þ IVa þ Ib 60%C
N68351 IIb þ IVa 36%C
N11566 IIba 70%C
N56070 IIba 83%C
N58795 IIb 65%C
N63539 IIb 70%C
N68683 IIb 63%C
N71212 IIba 74%C
N7118 IIba 65%C
ACCP ¼ amorphous carbonated calcium phosphate, Br ¼ b
COM ¼ whewellite, COD ¼ weddellite, MPS ¼ mucopolysaccharide
a Presence of large crystals of COD.visualisations derived from mComputed Tomography mea-
surements have been considered [36e42]. These charac-
terization techniques will allow us to assess the structural
parameters at micrometre and nanometre scales of these
pathological concretions [20e29].2. Material and methods
A set of 13 kidney stones ﬁrst examined under a ste-
reomicroscope for recording their main morphological
characteristics and second analysed by FTIR spectroscopy
[30,31] have been selected for the study (Table 1). Infrared
data were collected between 4000 and 400 cm1 with a
resolution of 4 cm1. The FTIR spectra show characteristic
absorption bands of the whewellite phase.
Observations through a last generation Field Emission
Scanning Electron Microscope (FE-SEM) for characteriza-
tion of the samples at the mesoscopic scale have been
performed [32]. Such apparatus offers the opportunity to
investigate nonconductive materials without any conduc-
tive coating and permits thus a direct observation causing
no damage for the sample. A set of observations have been
performed with a gaseous secondary electron detector at a
low accelerating voltage (under 2 kV).
Neutron diffraction patterns were collected on the G4.1
diffractometer [43] at Laboratoire Leon Brillouin [44] at
room temperature. This powder diffractometer is equipped
with a vertical focussing pyrolytic graphitemonochromator
and an 800-cell multidetector covering an 80 2q range
(step 0.1 between two cells). Neutron diffraction diagrams
were collected using a wavelength of 2.4226 Å, with an
acquisition time of a few hours on samples. Data analysisopy of the set of samples selected for this investigation.
analysis
COM
COM
COM
COM
OM þ 2%CA þ 2%PROT
OM þ 30%COD þ 3%CA þ 2%PROT
OM þ 28%COD þ 4%CA þ 3%PROT þ 1%MPS
OM þ 15%COD þ 3%CA þ 2%PROT
OM þ 17%CA þ 16%COD þ 10%ACCP þ 6%MAP þ 2%PROT
COM
OM þ 7%CA þ 4%PROT þ 2%MPS
OM þ 40%COD þ 5%CA þ 3%Br
OM þ 11%COD þ 6%CA þ 3%PROT
OD þ 35%COM þ 7%CA þ 2%PROT
OM þ 45%COD þ 3%CA þ 2%PROT
OM þ 26%COD þ 25%CA þ 10%WK þ 3%PROT
OM þ 21%CA þ 15%COD þ 4%PROT
OD þ 32%CA þ 28%COM þ 4%PROT
OM þ 25%COD þ 5%WK
OD þ 10%COM þ 4%CA þ 3%PROT
OD þ 19%COM þ 13%CA þ 3%PROT
OD þ 15%COM þ 7%CA þ 7%PROT þ 1%ACCP
OM þ 26%COD þ 8%CA þ 3%PROT
OD þ 20%COM þ 4%CA þ 2%PROT
OM þ 20%COD þ 8%WK þ 4%CA þ 3%PROT
rushite, CA ¼ carbonated calcium phosphate apatite,
s, MAP ¼ struvite, PROT ¼ proteins, and WK ¼ whitlockite.
D. Bazin et al. / C. R. Chimie 19 (2016) 1492e15031494was done using the FullProf program [45]. Details regarding
the data analysis procedure can be obtained elsewhere
[18,33e35].
For non-destructive three-dimensional (3D) scanning, a
set of kidney stones were selected and analysed with a
Quantum FX (Micro-CT Caliper PerkinElmer, Waltham, MA,
USA [46]) tomography system, equippedwith a 90 kV/20W
maximum power unipolar microfocus (5 mm focal spot)
X-ray tube and a high-contrast digital array detector
DXR250 with a 10 mm3 voxel, 5000  5000 mm pixel size
used. The mCT scan was performed for 3 min at 90 kV and
180 mA acceleration voltage and X-ray tube current,
respectively. The DICOM III data frames were subsequently
analysed using OsiriX imaging software (64 bits, 3.7.1
version). The scans resulted in reconstructed 3D data sets
with a voxel-size of 9.92 mm3 jointive slices.3. Results and discussion
Whewellite and weddellite stones may be easily
distinguished by very different morphological characteris-
tics as shown in Fig. 1.
In some cases, COM and COD crystals are clearly formed
independently, with well separated areas of calculi con-
taining either COM or COD (Fig. 2).Fig. 1. Macroscopic observations of COM and COD kidney stones. A and B: type
(C ¼ surface; D ¼ section).However, in a number of cases, the two crystalline forms
appear less clearly separated and even COM seems to be the
result of crystalline conversion from COD to COM as whe-
wellite is the thermodynamically stable form of calcium
oxalate. In such cases, the stone morphology is also sug-
gestive for such a transformation (Fig. 3).
Since the ﬁrst set of publications [47e50] dedicated to
calcium oxalate compounds, numerous studies of these
compounds were performed by different groups who
have addressed more deeply the crystallographic struc-
tures [51e59]. In fact, we can distinguish at least two
communities for which calcium oxalate constitutes an
important matter, urologists [60e66] and botanists
[67e71]. The fact that calcium oxalate is at the core of a
major public health problem explains the dynamism of
such research [72e81].
Regarding their crystallographic structure, the three
calcium oxalate forms (whewellite, weddellite and caoxite,
CaC2O4$3H2O) can be viewed as edge-shared CaO8 poly-
hedra that constitute the linkage between oxalate ions
[(C2O4)2] [51e59]. On the basis of this structural poly-
hedron model, whewellite, weddellite and caoxite are
composed of sheets, chains and dimers, respectively
[51e59].While the crystallographic structure of whewellite
and caoxite display a sheet structure consisting of Ca2þ ionsIa COM stone (A ¼ surface; B ¼ section) e C and D: type IIa COD stone
Fig. 2. Macroscopic observations of mixed COD þ COM stones: A ¼ surface e B ¼ section. Arrows correspond to COM areas.
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dellite one [51e59]. According to V. Tazzoli and C. Dome-
neghetti [55], such a structural similarity between
whewellite and caoxite allows a direct transformation of
caoxite into whewellite without an intermediate weddel-
lite stage [55]. More precisely, during the dehydration
process, interlayered water molecules in caoxite lead to
intralayered water molecules of the crystal structure of
whewellite. It should be noted that a precise examination
of the crystallographic structure of weddellite indicates the
existence of a channel in which free (extra framework)
water molecules occur in two alternative and very closeFig. 3. Macroscopic observations of mixed COM þ COD kidney stones. A to D exam
and C ¼ surface; B and D ¼ section.positions. Taking into account this structural speciﬁcity, the
maximum water content is 2.5 [55].
Thanks to their very different crystallographic struc-
tures [51e59] whewellite, the most stable as given by
thermodynamic and weddellite compounds, can be easily
distinguished using either vibrational spectroscopies such
as IR [82,83] or Raman [84] spectroscopy, diffraction tech-
niques [85,86] or microtomography [87]. Recent break-
throughs in theoretical chemistry allow a precise
assignation of the IR absorption bands. In our cases, all
these theoretical values for the IR absorption bands,
namely position as well as intensity, have been obtainedples of crystalline conversion from COD to COM in calcium oxalate stones. A
Fig. 4. FTIR spectra of pure COM (black) and COD (red).
Fig. 5. FTIR spectra of whewellite corresponding to a chemical conversion
fromweddellite. Crystalline conversion affects signiﬁcantly the intensity and
the shape of the IR absorption band (see the inset). IR absorption bands of
unusual (a and b), usual (c) and synthetic (d) whewellite.
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wave pseudopotential approach as implemented in VASP
[88,89]. The PerdeweBurkeeErnzerhof functional [90,91]
has been chosen to perform the periodic DFT calculations
with an accuracy on the overall convergence tested else-
where [92e95]. The valence electrons are treated explicitly
and their interactions with the ionic cores are described by
the Projector Augmented-Wave method [96,97], which al-
lows us to use a low energy cut off equal to 500 eV for the
plane-wave basis. The gamma point is used in the Brillouin-
zone integration. The positions of all the atoms in the super
cell are relaxed until the total energy differences decrease
below 104 eV. The atom positions as well as the unit cell
have been relaxed. From these results one can conclude
that the vibrational bands were well attributed, besides the
517 cm1 peak and bands in the region of 790e750 cm1,
which are attributed to the CeC stretching mode and a
mixing of COO wagging/stretching þ water rocking,
respectively. The vibrations implicating Ca2þ ions are ex-
pected to appear at much lower wave numbers (below
320 cm1). Regarding the contribution of water molecules
to the IR absorption spectrum, experimentally the bands in
the range of 3500e3200 cm1 are attributed to its sym-
metric and asymmetric stretch, whereas the strong peaks
around 1620 cm1 and the weak band at 661 cm1 are
assigned to its bending and wagging modes [98e100]. The
bands at 1664, 1316, 780 and 517 cm1 are due to sa(C]O),
ss(C]O), d (OeC]O) and s (CaeO).
At the hospital, crystalline conversion between whe-
wellite and weddellite is suspected through morphological
characteristics of calculi in both surface and section, and
also by a modiﬁcation of the IR absorption bands. Pure
weddellite or whewellite calculi exhibit a very different
infrared spectrum as shown in Fig. 4.
In Fig. 5, it is clearly seen that if the IR absorption bands
of the whewellite compounds are well identiﬁed, the
morphology as well as the position of the sa(C]O) ab-
sorption band (1618 cm1 for COM and 1640 cm1 for COD)
are signiﬁcantly different.
At this point, it is worth to underline that SEM obser-
vations allow us to compare the usual morphology of the
weddellite bipyramidal crystallite [53,101e103] displaying
surface without defects (Fig. 6a) and the ones corre-
sponding to the kidney stone N68097 (Fig. 6bee). As we
can see, a bipyramidal morphology exists with large
structural defects and observations at higher magniﬁca-
tion indicate that these defects follow the crystallographic
axis. In the literature, different studies have been dedi-
cated to the partial dissolution of the calcium oxalate
crystals observed in water, in the presence of EDTA
(ethylene diamino tetracetate) [104e109] or an extract of
green tea [110]. For example, P. Vijaya et al. [109] have
found that whewellite with a monoclinic structure is the
more favoured polymorph in the presence of EDTA. In the
case of calcium oxalate dihydrate crystals, corrosion ﬁg-
ures, in the form of etch square pits, can be present at the
surface [29,111]. The striking point of these observations is
given by the fact that the main component of the chemical
composition of this kidney stone as determined by FTIR is
whewellite indicating thus a strong conversion of the
initial weddellite bipyramide. Moreover, we mayunderstand the fact that part of the weddellite bipyramide
crystal disappears if we consider the volume of the unit
cell of the two calcium oxalates. The loss of more than one
water molecule in the structure (from whewellite
Fig. 6. A: SEM observations showing weddellite crystallites displaying their usual bipyramidal morphologies without alteration at their surface; B, C, D, E: SEM
observations obtained for the kidney stone N68097.
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along a signiﬁcant decrease of the volume of the unit cell
(V (Å3) is equal to 878.2 for whewellite, while V (Å3) is
equal to 1125 for weddellite).
Several publications have demonstrated that precious
information can also be obtained through X-ray tomogra-
phy [36e42]. In order to show the opportunities given by
X-ray tomography, a set of samples (N69923, N11566,N56070, N57404, N58795, N68683, N71212, and N7118)
have been investigated through a double-blind trial. At the
macroscopic scale, microtomography observations (Figs.
7e9) are able to distinguish between different structures
which correspond to very different pathologies. For Fig. 7,
structures corresponding to Ia kidney stones are associated
with intermittent and moderate hyperoxaluria of dietary
origin while in Fig. 8 the loose globular structure results
Fig. 7. Microtomography observations (A and B) revealing a concentric organisation inside the N68102 kidney stone in line with the fact that this kidney stone
belongs to the morphological type Ia as observed in Fig. 7C (surface) and 7D (section).
D. Bazin et al. / C. R. Chimie 19 (2016) 1492e15031498from high levels of urine oxalate concentration related to
an increase of oxalate absorption in patients who suffer
from inﬂammatory bowel diseases that have required ileal
resection. Finally, in Fig. 9, the stone is mainly composed of
COD crystals and is related to hypercalciuric states. The
interest of microtomography is that, thanks to the pene-
tration of hard X-rays, the determination of the different
structures can be performed in the bulk without any al-
terations of the 3D structure of the kidney stones. Such an
approach is a very ﬁrst step toward similar experiments
performed in vivo.
Observations of all the mCT measurements show clearly
that such an approach is able to point out the presence of
bipyramidemorphologies even in the bulk. Thus, structural
characteristics with signiﬁcant clinical information can be
obtained using mX-ray tomography.
Information at the nanometre scale can be gathered
using X-ray or neutron diffraction techniques [112e116].
At this point, we would like to recall the deﬁnition of
nanocrystals and crystallites as deﬁned by Van Meersscheand Feneau-Dupont [117] in order to describe the hierar-
chical structure of these pathological concretions. Crys-
tallites (measuring typically some tens of micrometres) are
made up of a collection of nanocrystals (measuring typi-
cally some hundreds of nanometres). Such characteriza-
tion tools can be considered as a non-destructive
microscope seeing inside matter. We have already used
this technique in the case of calcium oxalate, cystine,
struvite and uric acid kidney stones [18,33e35]. In Fig. 10,
a set of Neutron Powder Diffraction (NPD) diagrams have
been plotted. For some kidney stones, the signal to noise
ratio was enough to analyse the data through the FullProf
program. Such an approach leads to the knowledge of the
apparent mean size of the coherently diffracting crystals
from the observed broadened Bragg peaks of the NPD
stone diagrams taking into account the instrumental res-
olution function of the neutron diffractometer. The Full-
Prof program thus provided a value of this mean size
(80 nm) with its standard deviation. Fig. 11 is an example
of the diffraction pattern at room temperature of the
Fig. 8. A: Macroscopic observations of N69923 COM kidney stone. B: Colorized 3D microtomography of the stone. C: Different views of 3D microtomography
observations revealing a globular organisation inside the N69923 kidney stone in line with the fact that this kidney stone belongs to the morphological type Ie,
associated with enteric hyperoxaluria.
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high, owing to the hydrogen content of this biological
sample, the high quality of the diagram allowed for a
complete Rietveld-type reﬁnement with an excellent
RBragg factor (16.83). We used the crystallographic model
that we have already published [18]. We found that the
structural parameters (a, b, c and b) did not differ signiﬁ-
cantly from the values obtained previously. The signiﬁcant
difference we have between the experimental data and its
numerical simulations (red arrows on Fig. 11) comes from
the presence of weddellite (Fig. 12).
As a conclusion of these experiments related to the
conversion process of weddellite into whewellite, whe-
wellite kidney stones for which IR spectra are not usual, are
associated to classical NPD diagrams. As underlined by A.
Millan [118], whewellite presents an enantiotropic trans-
formation between 38 and 45 C. The high-temperature
structure belongs to space group I2/m with an unit cell:
a ¼ 9.978 Å, b ¼ 7.295 Å, c ¼ 6.292 Å, b ¼ 107.07. The low-
temperature structure belongs to space group P21/n, and it
has a double unit cell with dimensions: a ¼ 9.9763 Å,b ¼ 14.5884 Å, c ¼ 6.2913 Å, b ¼ 107.05. This trans-
formation is only distortional, and it hardly affects the bond
network [118]. Nevertheless, these two crystallographic
structures are associated to different NPD diagrams
(Fig. 13). Thus, the presence of the other polymorph could
affect the NPD of kidney stoneswhich is not observed in the
KS studied.
In order to assess this contradiction, the very same NPD
diagrams but different FTIR spectra, an analogy can be
drawn with Ca phosphate apatite [119e123]. For this
chemical compound, the presence of amorphous Ca phos-
phate apatite induces a modiﬁcation of the IR absorption
spectrum (Fig. 14) and is not detected for neutron
diffraction.
A simple hypothesis to explain our results is thus given
by the existence of an amorphous whewellite. Indeed, this
chemical phase has been recently synthetized [124]. At this
point, we can underline the fact why such amorphous
calcium oxalate has been synthetized only recently. One
explanation may come from the choice of precursors.
Among numerous publications dedicated to the synthesis
Fig. 9. A: Macroscopic observations of N56070 COD kidney stone. B: Colorized 3D microtomography of the COM kidney stone. C: Different views of 3D
microtomography observations revealing the absence of concentric layers inside the stone in line with the fact that this kidney stone belongs to the morpho-
logical type II. Of note, small whitish deposits dispersed within the section correspond to carbapatite deposits inside the stone.
Fig. 10. NPD diagrams of a set of kidney stones (N68097, N68214, N68231,
N68285, N68316, and N68351). The fact that the quantity of samples as
viewed by the neutron beam is not constant from one sample to another
explained the variation intensity of the background.
Fig. 11. Typical ﬁnal observed (Yobs in red), calculated (Ycalc) and difference
proﬁles (Yobs-Ycalc in blue) of the NPD diagram of the N68097 kidney stone.
Tick marks (Bragg position in green) below the proﬁles indicate the peak
positions of allowed Bragg reﬂections for whewellite.
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Fig. 12. NPD diagrams collected for synthetic weddellite and whewellite.
Fig. 13. NPD diagrams calculated for the two polymorphs of whewellite
which coexist at room temperature. On (A) our model and on (B) the other
polymorph.
Fig. 14. FT-IR absorption spectra of the compounds used here as references
(in red, hydroxy apatite (HAP); in blue, carbapatite (CA); in black, amor-
phous carbonated calcium phosphate (ACCP). Inset: n3 PO4 vibration.
Table 2
Precursors used for the synthesis of whewellite crystals.
Ca Oxalate References
CaCl2$2H2O (CH3)2C2O4 M. Hajir et al., 2014 [124]
Calcium
chloride (CaCl2)
Sodium
oxalate (Na2C2O4)
R. Zauner et al., 2000 [125],
J. Yu et al., 2005 [126],
S.-P. Deng et al., 2006 [127],
M. Liang et al., 2009 [128],
Z. Chen et al., 2010 [110],
X. Wei et al., 2012 [129],
K. Pitt et al., 2012 [130],
K.P. Aggarwal
et al., 2013 [131],
C. Conti et al., 2014 [85].
CaCl2$2H2O
or CaCl2
(COOH)2$2H2O G. Wiedemann
et al., 1988 [132]
H2C2O4 J.W. Kurutz
et al., 2003 [133],
K. Niimi et al., 2012 [134],
P. Vijaya et al., 2012 [109],
K. Akhtar et al., 2013 [135].
K2C2O4 D. Jauregui-Zuniga
et al., 2005 [136],
Rabinovich
et al., 2008 [137],
Y. Xiu-Qiong
et al., 2012 [138],
S. Zhang et al., 2012 [139].
Na2C2O4 T. Jung et al., 2005 [140]
Na2C2O4,
H2C2O4,
A. Millan, 2001 [118]
H2C2O4, Na2C2O4,
K2C2O4
J.-M. Ouyang
et al., 2005 [141]
Ca(NO3)2$4H2O Sodium oxalate
(Na2C2O4)
B. Grohe et al., 2012 [142]
Oxalic
acid (H2C2O4)
P. Thanasekaran
et al., 2012 [143]
Sodium
oxalate (Na2C2O4)
B.P.H. Chana
et al., 2012 [103]
Sodium
oxalate (Na2C2O4)
E.C. Arvaniti
et al., 2010 [144]
D. Bazin et al. / C. R. Chimie 19 (2016) 1492e1503 1501of whewellite (see in Table 2 selected examples), if different
kinds of precursors have been used, most of the syntheses
of calcium oxalate crystals are based on mixing CaCl2 and
Na2C2O4 solutions. Using (CH3)2C2O4 was a different way
which could explain why amorphous calcium oxalate has
been successfully synthetized. In the case of kidney stones,
such amorphous whewellite could be present as a result of
D. Bazin et al. / C. R. Chimie 19 (2016) 1492e15031502COD conversion at the surface of whewellite crystals or
coexisting with whewellite crystals. Only another set of
experiments based on X-ray absorption and NMR could
assess precisely the localisation of the amorphous whe-
wellite versus crystalline whewellite.
4. Conclusion
In this investigation, a set of kidney stones containing
whewellite and associated to a particular FTIR spectrum
have been considered. The complete set of data including
FE-SEM observations at the mesoscopic scale, NPD exper-
iments to assess their crystallographic structure at the
nanometre scale and 3D and 2D cross-section visual-
isations evaluated from the mCTmeasurements indicate the
presence of amorphous whewellite. This structural possi-
bility is quite similar to what is observed for calcium
phosphate apatite. Moreover, stable amorphouswhewellite
has recently been synthetized [69].
Such improvement in the structural description of cal-
cium oxalate compounds is of major importance for clini-
cians. According to the results presented in the paper, NPD
and mCT measurements do not show the presence of
amorphous whewellite contrary to FTIR and FE-SEM ob-
servations. These results imply that the quantity of amor-
phous calcium oxalate is quite low. Finally, such
improvement in the structural description of calcium oxa-
late compounds is of major importance for clinicians. The
presence of amorphous whewellite leads to hypercalciuria-
related and not to hyperoxaluria-related stones, while
crystalline whewellite is highly suggestive for hyper-
oxaluric states.Acknowledgements
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